Patterson Companies (PDCO) Expected to Announce Earnings on Wednesday

Patterson Companies (NASDAQ:PDCOGet Free Report) is expected to post its quarterly earnings results before the market opens on Wednesday, February 26th. Analysts expect Patterson Companies to post earnings of $0.62 per share and revenue of $1.63 billion for the quarter. Patterson Companies has set its FY25 guidance at $2.25-$2.35 EPS and its FY 2025 guidance at 2.250-2.350 EPS.

Patterson Companies (NASDAQ:PDCOGet Free Report) last announced its quarterly earnings results on Thursday, December 5th. The company reported $0.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Patterson Companies had a return on equity of 19.77% and a net margin of 2.37%. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the firm earned $0.50 earnings per share. On average, analysts expect Patterson Companies to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Patterson Companies Stock Up 0.0 %

Shares of NASDAQ PDCO opened at $31.07 on Monday. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of 18.17, a price-to-earnings-growth ratio of 2.71 and a beta of 0.90. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76. The business has a 50-day moving average of $30.93 and a two-hundred day moving average of $25.21. Patterson Companies has a 1 year low of $19.45 and a 1 year high of $31.79.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Piper Sandler decreased their price target on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, December 6th. Leerink Partners reaffirmed a “market perform” rating and set a $31.35 price target (up from $29.00) on shares of Patterson Companies in a report on Wednesday, December 11th. Stifel Nicolaus decreased their price target on Patterson Companies from $25.00 to $24.00 and set a “hold” rating for the company in a report on Thursday, December 5th. Robert W. Baird lifted their price target on Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a report on Thursday, December 12th. Finally, StockNews.com initiated coverage on Patterson Companies in a report on Sunday. They issued a “hold” rating for the company. Eleven research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $26.57.

Read Our Latest Report on Patterson Companies

Insider Buying and Selling at Patterson Companies

In other Patterson Companies news, CEO Donald Zurbay sold 1,962 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $23.08, for a total transaction of $45,282.96. Following the completion of the sale, the chief executive officer now directly owns 222,736 shares of the company’s stock, valued at $5,140,746.88. This represents a 0.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.90% of the stock is owned by company insiders.

About Patterson Companies

(Get Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

Featured Stories

Earnings History for Patterson Companies (NASDAQ:PDCO)

Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.